Jiangsu Recbio Technology Co Ltd HKEX:2179:
LI BU RESIGNED AS EXECUTIVE DIRECTOR
CHEN QINGQING RESIGNED AS AN EXECUTIVE DIRECTOR
HONG KUNXUE RESIGNED AS EXECUTIVE DIRECTOR
NOMINATED WEI QIFANG AND WANG JING AS EXECUTIVE DIRECTORS
Jiangsu Recbio Technology Says Li Bu Resigned As Executive Director
Jiangsu Recbio Technology Co., Ltd. on 6ix
Later from Jiangsu Recbio Technology
- Jiangsu Recbio Technology Says Liu Yong Resigned As Chair
- Jiangsu Recbio Technology Says New Drug Application For REC610 Shingles Vaccine Accepted By NMPA
- 2026 Interim Report
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Voluntary announcement receipt of phase III clinical trial summary report for novel adjuvanted recombinant shingles vaccine REC610
Follow Jiangsu Recbio Technology into a list and get an email when it puts out news.
Follow Jiangsu Recbio Technology